• AstraZeneca's Lynparza Could Be Transformed Into Precision Medicine For Prostate Cancer

    5 monthes ago - By Tech Times

    Following the development of a three-in-one blood test, AstraZeneca's drug Lynparza could be transformed into precision medicine for prostate cancer, experts said. Doing so could have a major impact in the treatment of prostate cancer patients.
    Read more ...